News: Variantyx Secures $20M in Funding for Whole Genome Sequencing Methodology, Advanced Testing Method that Diagnoses Genetic Disorders

March 15, 2021 Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding for their Whole Genome Sequencing …

Read More

Events: Annual Ataxia Conference

Join us at the 64th annual ataxia conference hosted by the National Ataxia Foundation where we have a full schedule of events planned.

Read More

Article: Whole genome sequencing and health insurance

When evaluating insurance policies, it’s important to know that whole genome sequencing (WGS) offers the most comprehensive testing available providing granular, actionable data from an individual’s DNA to diagnose and effectively treat many inherited disorders, including inherited cancers.

Read More

Variantyx Inc.

1671 Worcester Road, Suite 300
Framingham MA 01701 USA

Phone: +1 617-209-2090

  • This site is protected by reCAPTCHA and the Google Privacy and Terms of Service apply

Please do not submit Protected Health Information (PHI) through this email address.

If you need to submit Protected Health Information (PHI), please call us at 617-209-2090 and we will work with you to submit the information through an alternate mechanism.

Otherwise, please continue: